Introduction
miRNAs are small non-coding RNAs (18-22 nt in length) that regulate the expression of target genes at the post-transcriptional level by binding to their target mRNAs (1, 2) . Since their discovery in 1993, the number of verified miRNAs has grown rapidly, and the latest version of miRBase (release 20.0, June 2013, http://www.mirbase.org/) has annotated 2578 mature miRNA sequences in the human genome. miRNAs are estimated to regulate up to one-third of human genes at the post-transcriptional level (3) . miRNA deregulation has been demonstrated to play a role in the pathological processes of tumorigenesis (4, 5) . Furthermore, miRNAs serve as potential diagnostic markers, prognostics factors and therapeutic targets (6) (7) (8) (9) . Although miRNAs have been reported to be involved in human cancers, the biological functions and molecular mechanisms of them remain largely unknown.
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and the second most commonly diagnosed cancer in women worldwide. Over 1.2 million new cancer cases occur annually, resulting in greater than 600,000 deaths each year (10) . Despite recent advances in diagnostic and therapeutic measures, the prognoses of CRC patients remain poor. Therefore, it is necessary to clarify the underlying molecular mechanisms and to identify specific biomarkers of CRC. The timely discovery of the importance of miRNAs is fortunate in this regard.
Over the last decade, the contribution of miRNAs (11) , such as let-7 (12, 13) , miR-17 (14, 15) , miR-21 (16) (17) (18) (19) , miR-31 (20, 21) , miR-95 (22) , miR-101 (23, 24) , miR-135 (25, 26) , miR-137 (27) , miR-139 (28, 29) , miR-143 (30) (31) (32) , miR-145 (31, 33) , miR-155 (34) , miR-183 (35) and miR-195 (36) to colorectal carcinogenesis has been examined. In a previous study, we determined that miR-95 is frequently overexpressed in CRC and acts as an important inducer of proliferation via the negative regulation of SNX1 expression (22) . All these data highlight the importance of miRNAs in tumor development and provide new insights into the molecular mechanisms underlying carcinogenesis.
Our previous microarray data showed that miR-202-3p, a member of the let-7 family, was downregulated in CRC (22) . In addition to CRC, miR-202-3p has also been reported deregulated in breast cancer and cervical squamous cell carcinoma (37, 38) and could inhibit cell proliferation in neuroblastomas (39, 40) . These data suggest that miR-202-3p may play common roles on tumorigenesis. However, the detailed function and molecular mechanisms of miR-202-3p in human tumors have not been elucidated. In the present work, we confirmed that miR-202-3p expression was significantly decreased in CRC tissues compared with the noncancerous tissues (NCT) in an expanded CRC cohort. Moreover, we showed that miR-202-3p could inhibit cell proliferation by directly targeting ARL5A in CRC, and analysis on clinical tumor samples indicated that ARL5A is a new independent prognostic factor in CRC.
Research. (Table S1) were supplemented with 10% fetal bovine serum (Gibco, USA). The cells were incubated under the conditions recommended by ATCC.
Materials and Methods

Human tissues and cell lines
DNA and RNA extraction and quantitative real-time RT-PCR
Tissue genomic DNA was isolated using the DNeasy Blood and Tissue kit (Qiagen, German) according to the manufacturer's protocol. Total RNA, including miRNA, was extracted using the TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions. The concentrations of DNA and RNA were determined using a NanoDrop ND-1000 (NanoDrop, USA), and aliquots of the samples were stored at -80°C. Relative DNA copy numbers were determined by qPCR using SYBR Premix Ex Taq (TaKaRa, Japan). An amount of 50ng DNA was used as template in a final volume of 20 μL with LINE-1 as an internal control (41) (42) (43) . cDNA was synthesised with the PrimeScript RT reagent kit (TaKaRa, Japan) using 500ng total RNA as template. qPCR analyses were conducted to quantitate mRNA relative expression using SYBR Premix Ex Taq (TaKaRa, Japan) with beta-ACTIN as an internal control (44) (45) (46) USA) were used to determine the expression levels of miR-202-3p after reverse transcribed by sequence-specific primers (Applied Biosystems, USA), and U6 small nuclear RNA was used as an internal control (47) (48) (49) (50) . The results of qPCR were defined from the threshold cycle (Ct), and relative expression levels were calculated by using the 2 -△△Ct method (51) . PCR was performed using an ABI 7900HT instrument (Applied Biosystems, USA). The primers used for PCR analysis were listed in the Supplementary Data (Tables S2).
Vector constructs
The human pri-miR-202 sequence was amplified from normal human genomic DNA by nested PCR using PrimerSTAR Premix (TaKaRa, Japan). The sequence was then cloned into the lentivirus expression vector pGIPZ 
Microarray analysis
Genome-wide expression profiling was performed using an Agilent whole human genome oligo microarray chip (4×44K) that contains more than 42,034 genes and transcripts (Agilent, USA). A amount of 5×10 
Western blot
Harvested proteins were first separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and then transferred to nitrocellulose membranes (Bio-Rad Laboratories, USA). The membranes were blocked with 5% non-fat milk and incubated with a mouse anti-ARL5A polyclonal antibody at a dilution of 1:500 (Abgent, USA) or a mouse anti-beta-ACTIN monoclonal antibody at a dilution of 1:1,000 (Sigma, USA). The membranes were subsequently incubated with a goat anti-mouse horseradish peroxidase secondary antibody (Sigma, USA). The protein complex was detected using enhanced chemiluminescence reagents (Pierce, France).
Endogenous beta-ACTIN was used as the internal control.
Immunohistochemical staining
Tissue arrays were constructed using the 94 paired CRC tissues and NCTs.
Immunohistochemical staining was performed on 4 μm sections of paraffin-embedded tissues to determine the expression level of ARL5A protein.
In brief, the slides were incubated in ARL5A antibody (Abgent, USA) diluted 1:200 at 4°C overnight. The subsequent steps were performed using the EnVision™ FLEX High pH visualisation system according to the manufacturer's instructions (DAKO, Demark). The ARL5A staining intensity measurements are presented in the Supplementary Data ( Figure S2 ).
Statistical analyses
The results are presented as the mean values ± SEM. Overall survival rates were calculated actuarially according to the Kaplan-Meier method with log-rank test and were measured from the day of surgery. Differences between groups were estimated using the χ2 test, Student's t test, the Mann-Whitney U CRC tissues when compared to the corresponding NCTs (P < 0.001, Figure   1A ). However, there was no significant association between miR-202-3p expression in CRC tissues and gender, age, tumor location, tumor size, histological classification, nodal status or survival (P > 0.05, data not shown).
Results
Expression
In addition, miR-202-3p T:N expression ratios were weakly associated with overall survival (OS) of CRC patients (Supplementary Data, Figure S1A ).
Downregulation of miR-202-3p in CRC tissues caused by DNA deletion
To confirm the hypothesis that downregulation of miR-202-3p in CRC tissues was partly caused by copy number variation of its coding sequence, we determined the pre-miR-202 copy number by qPCR in 37 pairs of the CRC tissues and NCTs. Interestingly, we found that the copy number of pre-miR-202 was lower in 64.9% (24/37) and higher in 13.5% (5/37) of the CRC tissues compared with their NCT counterparts (P < 0.05, Figure 1B ). Subsequent analysis showed that the pre-miR-202 copy numbers were related to the expression levels of mature miR-202-3p in both the CRC and NCT samples (P < 0.05, Figures 1C, 1D) . Figure S1D ).
Screening of candidate target genes of miR-202-3p
To explore the potential mechanism by which miR-202-3p represses the Figure S4B ).
ARL5A protein was overexpressed in 56.4% (53/94) of the CRC tissues compared with the matched NCTs (P < 0.05, Figure 5B ) and clearly negatively correlated with miR-202-3p expression levels (P < 0.05, Figure 5C ). More importantly, enhanced immunoreactivity of ARL5A in CRC tissues was inversely correlated with overall survival (OS) and suggested a poor prognosis for the CRC patients (P < 0.01, Figure 5D ). Additionally, higher ARL5A protein levels in CRCs compared with NCTs also indicated poor prognosis ( Figure   S4C ). No association was observed between the intensity of ARL5A staining and tumor size, grade, stage or lymph node metastasis (P > 0.05). 5, 11 ). We previously reported that miR-95, which appears to be an oncogenic miRNA in CRC, promoted cell proliferation by directly targeting SNX1 (22) . In addition to upregulated miRNAs, downregulated miRNAs also contribute notably to tumorigenesis.
miR-139-5p, miR-145, miR-125a and miR-133a have been reported to be
tumor suppressors whose precise underlying mechanisms have been identified as they relate to the development of CRC (31, (53) (54) (55) .
With the aim of finding new CRC-associated miRNAs, we focused on miR-202-3p (previously named miR-202 before miRBase release 16.0), a target that was found to be significantly downregulated in CRC samples in our previous profiling data (22) . miR-202-3p is highly conserved across animal species and is now considered a member of the let-7 family, which consists of tumor suppressors that target k-RAS and MYCN (12, 39, 40) . Consistent with the role of let-7 family members, in this study, we found that miR-202-3p repressed cell proliferation and colony formation in CRC via its direct target, ARL5A. In addition to affecting proliferation, the role of miR-202-3p in metastasis is another important aspect that must be considered in future tumor-related research. However, we didn't conduct in-depth study on the 
effect of miR-202-5p on cell growth and found that overexpressing of miR-202-5p did not affect CRC cell proliferation (Supplementary Data, Figure   S1C ). Thus, we excluded the side effect of miR-202-5p overexpression in functional assays using cells that stably expressed miR-202.
Copy number variants (CNVs) have been described as notable structural variations in the human genome that affect gene expression and contribute to phenotypic differences (57, 58) . However, only a few studies have closely examined the CNVs of miRNAs and recognised their potential consequences.
The coding sequence of miR-202-3p is located on chromosome 10q26.3, a region considered a chromosome fragile site that is frequently deleted in endometrial and brain tumors (59, 60) . We observed that the copy numbers of (61, 62) . ARL5A is upregulated in liver carcinoma according to a previous report (62) . In our study, ARL5A was identified as a direct target of miR-202-3p using a series of assays. We demonstrated that ARL5A is upregulated in CRC tissues, promotes proliferation, and is a prognostic factor in CRC patients. These data suggest, for the first time, that ARL5A is a potential oncogene in CRC. However, the detailed mechanism by which ARL5A influences CRC cell growth has not yet been elucidated. Further study about other cell growth related genes in CRC (LRIG3 and CPEB4) may be carried through in the future work. 
